Thomas R. Staab II
2012
In 2012, Thomas R. Staab II earned a total compensation of $517.3K as Senior Vice President and Chief Financial Officer at BioCryst Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Option Awards | $103,122 |
|---|---|
| Salary | $375,167 |
| Stock Awards | $26,488 |
| Other | $12,500 |
| Total | $517,277 |
Staab received $375.2K in salary, accounting for 73% of the total pay in 2012.
Staab also received $103.1K in option awards, $26.5K in stock awards and $12.5K in other compensation.
Rankings
In 2012, Thomas R. Staab II's compensation ranked 8,658th out of 11,487 executives tracked by ExecPay. In other words, Staab earned more than 24.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,658 out of 11,487 | 25th |
Division Manufacturing | 3,147 out of 4,253 | 26th |
Major group Chemicals And Allied Products | 841 out of 1,198 | 30th |
Industry group Drugs | 614 out of 920 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 101 out of 160 | 37th |
Source: SEC filing on April 10, 2015.
Staab's colleagues
We found four more compensation records of executives who worked with Thomas R. Staab II at BioCryst Pharmaceuticals in 2012.
2012
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2012
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2012
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2012
David McCullough
BioCryst Pharmaceuticals